Ireland - English - HPRA (Health Products Regulatory Authority)

mcneil healthcare (ireland) ltd - triprolidine hydrochloride; dextromethorphan hydrobromide - syrup - 5 mg/0.625 mg/5ml - other cold preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - clarithromycin - modified-release tablet - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections caused by susceptible organisms. indications include:
lower respiratory tract infections for example bronchitis and pneumonia.
upper respiratory tract infections for example sinusitis and pharyngitis.
skin and soft tissue infections for example folliculitis, cellulitis and erysipelas.

Malta - English - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - clarithromycin - film-coated tablet - clarithromycin 250 mg - antibacterials for systemic use

Malta - English - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - clarithromycin - film-coated tablet - clarithromycin 500 mg - antibacterials for systemic use

Malta - English - Medicines Authority

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - film-coated tablet - clarithromycin 500 mg - antibacterials for systemic use

Australia - English - Department of Health (Therapeutic Goods Administration)

nutrivital pty ltd - lactobacillus delbrueckii ssp bulgaricus, quantity: 0.25 billion cfu; lactobacillus plantarum, quantity: 15 billion cfu; bifidobacterium longum, quantity: 2 billion cfu; fructooligosaccharides, quantity: 100 mg; lactobacillus salivarius ssp salivarius, quantity: 1.25 billion cfu; bifidobacterium lactis, quantity: 2 billion cfu; lactobacillus rhamnosus, quantity: 2 billion cfu; inulin, quantity: 150 mg; lactobacillus casei, quantity: 1.25 billion cfu; bifidobacterium breve, quantity: 1.25 billion cfu; lactobacillus acidophilus, quantity: 15 billion cfu; lactobacillus paracasei, quantity: 10 billion cfu - capsule, hard - excipient ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum - maintain/support general health and wellbeing ; maintain/support intestinal health ; maintain/support intestinal good/beneficial/friendly flora ; maintain/support small intestine good/beneficial/friendly flora ; maintain/support gastrointestinal system health ; maintain/support gastrointestinal mucosal membrane health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support healthy gastrointestinal immune function

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medochemie ltd (factory az) - clarithromycin - tablets film-coated - 500mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medochemie ltd (factory az) - clarithromycin - tablets film-coated - 250mg

Malta - English - Medicines Authority

nexcape pharmaceuticals (t/a enexi healthcare) 20-22, wenlock road, london, n1 7gu,, united kingdom - clarithromycin - film-coated tablet - clarithromycin 250 milligram(s) - antibacterials for systemic use

Malta - English - Medicines Authority

nexcape pharmaceuticals (t/a enexi healthcare) 20-22, wenlock road, london, n1 7gu,, united kingdom - clarithromycin - film-coated tablet - clarithromycin 500 milligram(s) - antibacterials for systemic use